Related Experiment Video
Updated: Jun 19, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Current understanding of the role of PPARγ in gastrointestinal cancers
Bing Zou1, Liang Qiao, Benjamin C Y Wong
1Department of Medicine; Centre Cancer Research, The University of Hong Kong, Pok Fu Lam Road, Hong Kong.
Abstract:
Numerous studies have indicated that PPARγ plays multiple roles such as in inflammation, cell cycle control, cell proliferation, apoptosis, and carcinogenesis, thus PPARγ contributes to the homeostasis. Many in vitro studies have showed that ligand-induced activation of PPARγ possess antitumor effect in many cancers including CRC. However, the role of PPARγ in gastrointestinal cancers, especially in colorectal cancer, is rather controversial. Nevertheless, some recent studies with the positive results on the possible application of PPARγ ligands, such as Bezafibrate or Rosiglitazone in gastrointestinal cancers, have suggested a potential usefulness of PPARγ agonists in cancer prevention and therapy. In this review, the authors discuss the recent developments in the role of PPARγ in gastrointestinal cancers.
Insights
Peroxisome proliferator-activated receptor gamma (PPARγ) has varied roles in cancer, and while its activation shows antitumor effects, its precise role in colorectal cancer remains debated. Recent findings suggest potential therapeutic applications for PPARγ agonists in gastrointestinal cancers.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Peroxisome proliferator-activated receptor gamma (PPARγ) is implicated in cellular processes including inflammation, cell cycle, proliferation, apoptosis, and carcinogenesis, contributing to cellular homeostasis.
- In vitro studies demonstrate that ligand-induced activation of PPARγ exhibits antitumor effects in various cancers, including colorectal cancer (CRC).
- However, the specific role of PPARγ in gastrointestinal cancers, particularly CRC, is a subject of ongoing controversy.
Purpose of the Study:
- To review recent developments concerning the role of PPARγ in gastrointestinal cancers.
- To discuss the potential therapeutic applications of PPARγ agonists in cancer prevention and treatment.
Main Methods:
- Literature review of recent studies on PPARγ in gastrointestinal cancers.
- Analysis of in vitro and in vivo data regarding PPARγ activation and its effects.
Main Results:
- PPARγ activation has demonstrated antitumor effects in numerous cancer types.
- Recent studies suggest potential benefits of PPARγ ligands like Bezafibrate and Rosiglitazone in gastrointestinal cancers.
- The precise role of PPARγ in colorectal cancer requires further elucidation due to conflicting evidence.
Conclusions:
- PPARγ agonists show promise for cancer prevention and therapy in gastrointestinal malignancies.
- Further research is warranted to clarify the controversial role of PPARγ in colorectal cancer and optimize therapeutic strategies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Gastritis II: Pathophysiology
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
